Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

10.1016/j.vaccine.2021.03.040

Saved in:
Bibliographic Details
Main Authors: Phua, LC, Choi, HCW, Wu, J, Jit, M, Low, J, Ng, K, Pearce, F, Hall, C, Abdul Aziz, MI
Other Authors: DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format: Article
Published: Elsevier BV 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/206124
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-206124
record_format dspace
spelling sg-nus-scholar.10635-2061242024-04-25T06:05:28Z Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore Phua, LC Choi, HCW Wu, J Jit, M Low, J Ng, K Pearce, F Hall, C Abdul Aziz, MI DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) OBSTETRICS & GYNAECOLOGY PHARMACY Bivalent vaccine Cervical cancer Cost-effectiveness Human papillomavirus Nonavalent vaccine Transmission dynamic model Adolescent Cost-Benefit Analysis Female Humans Papillomavirus Infections Papillomavirus Vaccines Quality-Adjusted Life Years Singapore Uterine Cervical Neoplasms Vaccination 10.1016/j.vaccine.2021.03.040 Vaccine 39 16 2255-2263 2021-11-15T02:41:53Z 2021-11-15T02:41:53Z 2021-04-15 2021-11-10T08:45:42Z Article Phua, LC, Choi, HCW, Wu, J, Jit, M, Low, J, Ng, K, Pearce, F, Hall, C, Abdul Aziz, MI (2021-04-15). Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore. Vaccine 39 (16) : 2255-2263. ScholarBank@NUS Repository. https://doi.org/10.1016/j.vaccine.2021.03.040 0264410X 18732518 https://scholarbank.nus.edu.sg/handle/10635/206124 Elsevier BV Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Bivalent vaccine
Cervical cancer
Cost-effectiveness
Human papillomavirus
Nonavalent vaccine
Transmission dynamic model
Adolescent
Cost-Benefit Analysis
Female
Humans
Papillomavirus Infections
Papillomavirus Vaccines
Quality-Adjusted Life Years
Singapore
Uterine Cervical Neoplasms
Vaccination
spellingShingle Bivalent vaccine
Cervical cancer
Cost-effectiveness
Human papillomavirus
Nonavalent vaccine
Transmission dynamic model
Adolescent
Cost-Benefit Analysis
Female
Humans
Papillomavirus Infections
Papillomavirus Vaccines
Quality-Adjusted Life Years
Singapore
Uterine Cervical Neoplasms
Vaccination
Phua, LC
Choi, HCW
Wu, J
Jit, M
Low, J
Ng, K
Pearce, F
Hall, C
Abdul Aziz, MI
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
description 10.1016/j.vaccine.2021.03.040
author2 DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
author_facet DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Phua, LC
Choi, HCW
Wu, J
Jit, M
Low, J
Ng, K
Pearce, F
Hall, C
Abdul Aziz, MI
format Article
author Phua, LC
Choi, HCW
Wu, J
Jit, M
Low, J
Ng, K
Pearce, F
Hall, C
Abdul Aziz, MI
author_sort Phua, LC
title Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
title_short Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
title_full Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
title_fullStr Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
title_full_unstemmed Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
title_sort cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in singapore
publisher Elsevier BV
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/206124
_version_ 1800915068544614400